By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    healthcare cybersecurity
    4 Helpful Tips on How to Protect Your Medical Practice Against Cyber Attacks
    October 24, 2021
    Health Check Diagnosis Medical Condition Analysis Concept
    6 Health Woes With Online Remedies
    January 19, 2022
    Eight Things Men Should Know About the Male Menopause
    Eight Things Men Should Know About the Male Menopause
    April 24, 2022
    Latest News
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
    The Hidden Impact Of Stress On Your Body’s Alignment And Balance
    May 22, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Does Insurance Cover the Cost of Therapy?
    June 14, 2022
    mental health loss loved one
    Covering Your Own Medical Issues After Losing a Loved One
    July 21, 2024
    healthcare SaaS
    Venture Capital Trends for Healthcare SaaS Platforms
    May 24, 2024
    Latest News
    Cigarette Makers Sue the FDA Over New Labeling Rules
    July 8, 2025
    End-Use Verification: Simple but Potentially Powerful
    July 8, 2025
    How Much do Financial Incentives Matter to Physicians?
    July 8, 2025
    NanoViricides Reports Positive Anti-viral Effect of HIV Drug
    July 8, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: HIPAA Marketing Rule Guidance: Better Than Nothing
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Health Reform > HIPAA Marketing Rule Guidance: Better Than Nothing
BusinessHealth ReformHospital AdministrationMedical RecordsPolicy & LawPublic Health

HIPAA Marketing Rule Guidance: Better Than Nothing

David Harlow
David Harlow
Share
7 Min Read
SHARE

61800551_5f5a2485ce_zThe HITECH Act made some significant changes to the HIPAA Privacy Rule, updating some provisions and increasing protections for individuals.

61800551_5f5a2485ce_zThe HITECH Act made some significant changes to the HIPAA Privacy Rule, updating some provisions and increasing protections for individuals. Improvement of regulatory schemes that are a little long in the tooth is laudable, since technical and societal changes, of necessity, make for a perpetual game of catch-up. However, it is a challenge for regulators to pick the right battles to fight, and the challenge is made that much more difficult to navigate when, as in the case of the HITECH Act, Congress gets into the weeds with extremely detailed statutory language, thus limiting the regulators’ range of discretion. Since it is often difficult for Congress to act, and even more difficult for it to act rationally, the detailed language of the HITECH Act hamstrings the regulators and the regulated community.

The increased privacy protections include limits on research, fundraising and marketing. Some of the restrictions in the new marketing rule have, in particular, caught the eye of the regulated community.

On the eve of the effective date of the Omnibus Rule, a commercial free speech challenge to the HIPAA marketing rule was brought in federal court, yielding an agreement by the federales to not enforce that portion of the rule (temporarily) and issue subregulatory guidance clarifying the rule to the satisfaction of the litigants. OCR posted the clarifying guidance regarding refill reminders for drugs and biologics.

More Read

Apple Watch
Apple Watch: Not a Digital Health Breakthrough – Yet
Patient and Family Advisory Council: Lessons Learned
Could Orphan Drugs Turn Health Economics on its Ear?
Innovating Technology to Drive Collaborative Care [VIDEO]
Bone Density Tests – Too Many Not a Good Thing

This guidance did not address all open questions.

I assisted a client recently in seeking additional subregulatory guidance from OCR. My client’s issue was centered on the limitation on remuneration for communication to patients — appointment reminders for eye exams — where these established patients had not previously authorized their eye care professionals to contact them by mail with information about appointments or new types of contact lenses. The reminders do not fall into the category of refill reminders because contact lenses are neither drugs nor biologics (though they are also prescribed and they are not liable to marketing abuses that differ from those relevant to drugs and biologics; they are not high-cost, high-risk implantable medical devices).

Interestingly, the Marketing Rule (and related definitions) permits the use of informational kiosks and displays in the practitioner’s office without advance authorization from the patient. Speaking for myself, I would much rather receive information by mail or email so that I may review it at my leisure and do a little on-line research. It’s not just me: A large proportion of the public prefers to receive marketing information in a manner that allows individuals to review and absorb information at their convenience, and to formulate questions for review with clinicians or other sellers at a later date.

85% of consumers think email, text messages, and voicemails are as helpful as in-person or phone conversations with their healthcare providers. But patients would rather receive via email feedback following in-person visits with their doctors (59%), notices for seasonal health offers such as flu shots (55%), and payment reminders (56%) than receive this information via text message, phone call, or voicemail, according to the survey. For patient care between visits, 49% of patients said they prefer email communication.

(Emphasis supplied.) How to Master Electronic Communication with Patients by Julia Brown, Medical Economics (April 10, 2013). See also: Foresee Press Release on Social Media vs. Traditional Advertising (February 3, 2011) (email preferred by consumers to social media contacts).

Frankly, in this day and age, we thought that it might be time for sub-regulatory guidance expanding the definition of “face-to-face” communications (a term not defined in the regulations) beyond communications between individuals in the same room. At the very least, we thought that that might be somewhere for OCR to hang its hat in extending itself a bit.

In the end, we were unable to obtain guidance that fully addressed our issues. However, OCR was willing to issue guidance that describes some permitted marketing activities — though it falls short of what we sought, and what we thought made sense from a policy perspective. I respect the perspective of the regulators, and the desire to stick within the boundaries of existing regulatory language and commentary.

Letter from Susan McAndrew, OCR, on the Marketing Rule

The key highlights from the OCR letter:

[C]ommunications about products or services that do not fall within the refill reminder exception for one or more reasons are still permitted under the Privacy Rule without authorization if . . . [t]he communications describe the availability of new developments or generations of contact lenses in only a general manner (e.g., do not identify a particular product or brand). For example, an eye care practitioner or its business associate could mail recall notices to individuals that describe in a general, non-brand specific manner new attributes of contact lenses that the individual may wish to inquire about when he or she comes to the office for an eye exam, even if such communications are paid for by the manufacturer of the contact lenses.

. . .

[In addition, covered entities and busines associates] may continue to provide to individuals promotional gifts of nominal value, such as brand-named pens, calendars, etc.,without prior written authorization from the individual.

Good as far as it goes — it does outline a range of permitted activity for the client going forward — but it doesn’t go far enough.

Either HHS or Congress should act to expand the very narrowly limited range of permitted activity in the marketing of certain low cost, low risk devices requiring a prescription.

TAGGED:HIPAA
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Health Care Buzz Today
Business
July 8, 2025
As We Mature (age), Things Change…
Orthopaedics
July 8, 2025
FDA Approves Roche (Genentech) Skin Cancer Drug–Zelboraf
Business
July 8, 2025
Smart Money on Pfizer?
Business
July 8, 2025

You Might also Like

patient centricity healthcare marketing
BusinesseHealthMedical DevicesMedical InnovationsMobile HealthSocial Media

Patient Centricity and Healthcare Marketing

March 15, 2016

Dual Eligibles in the U.S.: Statistics and Facts

October 16, 2013
lyme disease vaccine
Public Health

Lyme Disease Vaccine: Cautionary Tale or Opportunity for Renewed Activism?

October 4, 2013

Attacking Heart Disease in Inequality Land

July 8, 2025
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?